DOUBLE-BLIND PLACEBO-CONTROLLED PHASE-II TRIAL OF DIPHTHERIA-INTERLEUKIN-2 FUSION TOXIN (DAB486IL-2) IN PATIENTS WITH REFRACTORY RHEUMATOID-ARTHRITIS (RA)

被引：0
|
作者：
MORELAND, LW
SEWELL, KL
SULLIVAN, WF
SHMERLING, RH
PARKER, KC
SWARTZ, WG
WOODWORTH, TG
TRENTHAM, DE
KOOPMAN, WJ
机构：
[1] UNIV ALABAMA,BIRMINGHAM,AL 35294
[2] BETH ISRAEL HOSP,BOSTON,MA 02215
[3] SERAGEN INC,HOPKINTON,MA
来源：
ARTHRITIS AND RHEUMATISM | 1993年 / 36卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [1] TREATMENT OF REFRACTORY RHEUMATOID-ARTHRITIS WITH DAB(486)IL-2 FUSION TOXIN - DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    MORELAND, LW
    SEWELL, KL
    SULLIVAN, WF
    SHMERLING, RH
    PARKER, KC
    SWARTZ, WG
    WOODWORTH, TG
    KOOPMAN, WJ
    TRENTHAM, DE
    CLINICAL RESEARCH, 1993, 41 (02): : A245 - A245
  • [2] TREATMENT OF REFRACTORY RHEUMATOID-ARTHRITIS WITH DAB(486)IL-2 FUSION TOXIN - DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    MORELAND, LW
    SEWELL, KL
    SULLIVAN, WF
    SHMERLING, RH
    PARKER, KC
    SWARTZ, WC
    WOODWORTH, TG
    KOOPMAN, WJ
    TRENTHAM, DE
    ARTHRITIS AND RHEUMATISM, 1993, 36 (05): : R24 - R24
  • [3] INTERLEUKIN-2 DIPHTHERIA FUSION PROTEIN (DAB(486)IL-2) IN REFRACTORY RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL EXTENSION
    MORELAND, LW
    SEWELL, KL
    TRENTHAM, DE
    BUCY, RP
    SULLIVAN, WF
    SCHROHENLOHER, RE
    SHMERLING, RH
    PARKER, KC
    SWARTZ, WG
    WOODWORTH, TG
    KOOPMAN, WJ
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 1177 - 1186
  • [4] DAB(486)IL-2 IN RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL CONTINUATION
    SEWELL, KL
    MORELAND, LW
    SULLIVAN, WF
    SHMERLING, RH
    PARKER, KC
    SWARTZ, WG
    WOODWORTH, TG
    KOOPMAN, WJ
    TRENTHAM, DE
    ARTHRITIS AND RHEUMATISM, 1993, 36 (05): : R31 - R31
  • [5] DAB(486)IL-2 FUSION TOXIN IN REFRACTORY RHEUMATOID-ARTHRITIS
    SEWELL, KL
    PARKER, KC
    WOODWORTH, TG
    REUBEN, J
    SWARTZ, W
    TRENTHAM, DE
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : 1223 - 1233
  • [6] MINOCYCLINE IN ACTIVE RHEUMATOID-ARTHRITIS (RA) - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    KLOPPENBURG, M
    BREEDVELD, FC
    TERWIEL, JP
    MALLEE, C
    DIJKMANS, BAC
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S47 - S47
  • [7] SUPPRESSION OF IN-VITRO IGM AND IGM RHEUMATOID-FACTOR PRODUCTION BY DAB486IL-2 FUSION TOXIN THERAPY IN RHEUMATOID-ARTHRITIS (RA)
    SCHROHENLOHER, RE
    KOOPMAN, WJ
    WOODWORTH, TG
    MORELAND, LW
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S130 - S130
  • [8] SULFASALAZINE IN RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    PINALS, RS
    KAPLAN, SB
    LAWSON, JG
    HEPBURN, B
    ARTHRITIS AND RHEUMATISM, 1986, 29 (12): : 1427 - 1434
  • [9] Suppression of in vitro IgM rheumatoid factor production by diphtheria toxin interleukin 2 recombinant fusion protein (DAB(486)IL-2) in patients with refractory rheumatoid arthritis
    Schrohenloher, RE
    Koopman, WJ
    Woodworth, TG
    Moreland, LW
    JOURNAL OF RHEUMATOLOGY, 1996, 23 (11) : 1845 - 1848
  • [10] PHASE-I/II, DOUBLE-BLIND, DOSE-RESPONSE TRIAL OF 2ND FUSION TOXIN, DAB(389)IL-2, IN RHEUMATOID-ARTHRITIS
    SEWELL, KL
    MORELAND, LW
    CUSH, JJ
    FURST, DE
    WOODWORTH, TG
    MEEHAN, RT
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S130 - S130
12345